More Business Wire

View Older Stories View Newer Stories

Oct 13, 2023 08:00AM Franklin Templeton Closed-End Funds Announce Share Repurchases for the Third Quarter of 2023
Oct 13, 2023 08:00AM InterVenn Biosciences Announces the Publication of Early Detection of Advanced Adenoma and Colorectal Cancer in Gastroenterology, the Flagship Journal of the American Gastroenterological Association
Oct 13, 2023 08:00AM Citigroup Reports Third Quarter 2023 Results
Oct 13, 2023 08:00AM ABION Presents New Efficacy Data for ABN401, a Novel MET TKI for Advanced Non-Small Cell Lung Cancer
Oct 13, 2023 08:00AM Soluna Announces Implementation of 1-for-25 Reverse Stock Split
Oct 13, 2023 08:00AM BioTools Innovator Names Limula 2023 Winner
Oct 13, 2023 08:00AM Marcus & Millichap, Inc. to Report Third Quarter 2023 Financial Results on Friday, November 3, 2023
Oct 13, 2023 08:00AM Comcast Expands Broadband Network to Pelahatchie, Mississippi
Oct 13, 2023 08:00AM Dermavant Champions a Culture that Earns Three Best Workplace Rankings in 2023 by Fortune and Great Place to Work®
Oct 13, 2023 08:00AM Sonoma Biotherapeutics to Present Preclinical Data from Novel Treg Cell Therapy at Symposium on Hidradenitis Suppurativa Advances
Oct 13, 2023 08:00AM FOXO Technologies Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers
Oct 13, 2023 08:00AM Data From Incyte’s Povorcitinib Clinical Program to Be Featured at the 8th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA)
Oct 13, 2023 08:00AM The Bancorp, Inc. Sets Third Quarter 2023 Financial Results Release Date and Conference Call
Oct 13, 2023 08:00AM Bright Health Group to Host Third Quarter 2023 Earnings Conference Call on November 7, 2023
Oct 13, 2023 08:00AM Masimo ORi™ Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental Oxygen
Oct 13, 2023 08:00AM SOTIO Provides Update on Interim Data from Clinical Trials of Nanrilkefusp Alfa
Oct 13, 2023 08:00AM Boundless Bio Presents Preclinical Data on the Discovery of its Second ecDNA-Directed Therapeutic Candidate, BBI-825, at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cance
Oct 13, 2023 07:59AM Power Integrations to Release Third-Quarter Financial Results on November 7
Oct 13, 2023 07:45AM Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for HER2-Negative Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma Ex
Oct 13, 2023 07:45AM Amylyx Pharmaceuticals Receives Negative CHMP Opinion on its Marketing Authorisation Application for AMX0035 for the Treatment of ALS in the European Union Following Re-Examination Process
Oct 13, 2023 07:30AM CMCT Declares Preferred Stock Dividends
Oct 13, 2023 07:30AM Bowman Acquires South Carolina Firm Dennis Corporation
Oct 13, 2023 07:30AM Legends Real Estate Joins The Real Brokerage
Oct 13, 2023 07:05AM The Cannabist Company to Report Third Quarter 2023 Results on November 14, 2023
Oct 13, 2023 07:01AM Appalachian Regional Clean Hydrogen (ARCH2) Selected by the Department of Energy (DOE) to Develop Multi-State Clean Hydrogen Hub
Oct 13, 2023 07:00AM Xcel Energy, Heartland Hydrogen Hub selected for up to $925 million federal award
Oct 13, 2023 07:00AM JPMorgan Chase Reports Third-Quarter 2023 Financial Results
Oct 13, 2023 07:00AM SunOpta Announces Sale of Frozen Fruit Assets for an Aggregate Purchase Price of $141 Million Along With Preliminary Results for Third Quarter Fiscal 2023 and CFO Transition
Oct 13, 2023 07:00AM Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access (AVA) Annual Scientific Meeting in Portland, OR
Oct 13, 2023 07:00AM Capella University is Reaffirmed Among Select Institutions Offering Project Management Degree Programs
Oct 13, 2023 07:00AM Enanta Pharmaceuticals to Host Virtual Key Opinion Leader Event to Discuss Advances in the Treatment Landscape for Respiratory Syncytial Virus (RSV) and its Proprietary RSV Pipeline
Oct 13, 2023 07:00AM ZT Systems Unveils Future Cloud Computing Manufacturing Site in Greater Austin, Texas Area
Oct 13, 2023 07:00AM Alliance Resource Partners, L.P. Announces Third Quarter 2023 Earnings Conference Call
Oct 13, 2023 07:00AM Innovative Industrial Properties to Report 2023 Third Quarter Results
Oct 13, 2023 06:59AM Wells Fargo Reports Third Quarter 2023 Financial Results
Oct 13, 2023 06:39AM Birthright-Taglit Young Executive Forum Addresses Concerns to McGill University Regarding Responses to Violent Conflicts
Oct 13, 2023 06:38AM Galderma Unveils Bold Ambition in Neuromodulation at Liquid Live Event
Oct 13, 2023 06:37AM Birthright-Taglit Young Executive Forum Expresses Grave Concern Over Starbucks Union’s Endorsement of Violent Acts
Oct 13, 2023 06:30AM Vertex Energy Provides Operational Update for Third Quarter 2023
Oct 13, 2023 06:30AM Terran Orbital Opens New Printed Circuit Board Assembly Facility
Oct 13, 2023 06:15AM BlackRock Reports Third Quarter 2023 Earnings
Oct 13, 2023 06:00AM Defiance's Suite of Daily Options (0DTE) Income ETFs, $QQQY & $JEPY, Surpass $100M AUM in less than 30 Days
Oct 13, 2023 06:00AM NW Natural Holdings Schedules Earnings Release and Conference Call for Friday, November 3
Oct 13, 2023 06:00AM Five Point Holdings, LLC Sets Date for Third Quarter 2023 Earnings Announcement and Investor Conference Call
Oct 13, 2023 05:55AM UnitedHealth Group Reports Third Quarter 2023 Results
Oct 13, 2023 05:36AM LEO Pharma Presents Phase 3 Results of Delgocitinib Cream for Adults with Moderate to Severe Chronic Hand Eczema (CHE) at EADV 2023
Oct 13, 2023 05:27AM LEO Pharma Presents New Long-Term Data on Use of Adtralza® (tralokinumab) to Treat Moderate-to-Severe Atopic Dermatitis (AD)
Oct 13, 2023 05:00AM Almirall's Lebrikizumab Improves Signs and Symptoms of Moderate-to-Severe Atopic Dermatitis (AD) in Patients Inadequately Controlled With or Ineligible for Cyclosporine¹
Oct 13, 2023 04:30AM Tikehau Capital: Disclosure of Shares Repurchases From 6 October to 12 October 2023
Oct 13, 2023 03:00AM AM Best Europe Insurance Market Briefing to Examine State of Industry Amid Escalating Challenges; Beazley CEO to Deliver Keynote
View Newer Stories View Older Stories